The beta agonist lung injury trial prevention. A randomized controlled trial. - Wikidata - wikimedia - TriplyDB

The beta agonist lung injury trial prevention. A randomized controlled trial.

The beta agonist lung injury trial prevention. A randomized controlled trial.

http://www.wikidata.org/entity/Q37698243

about

Emerging therapies for the prevention of acute respiratory distress syndrome Prevention of acute respiratory distress syndrome Reply: β2-agonists and acute respiratory distress syndrome Preventing ARDS: progress, promise, and pitfalls Regulation of β-adrenergic receptor trafficking and lung microvascular endothelial cell permeability by Rab5 GTPase.Evidence for chemokine synergy during neutrophil migration in ARDS Pathophysiology of acute lung injury following esophagectomy.Update in Mechanical Ventilation, Sedation, and Outcomes 2014.Perioperative "remote" acute lung injury: recent update.Fifty Years of Research in ARDS. Is Acute Respiratory Distress Syndrome a Preventable Disease?Inhalation therapies in acute respiratory distress syndrome.β2-agonists and acute respiratory distress syndrome Importance of the kidney, vessels, and heart with administration of β2 adrenergic receptor agonists in patients susceptible to acute respiratory distress syndrome.Reply: Importance of the kidney, vessels, and heart with administration of β2 adrenergic receptor agonists in patients susceptible to acute respiratory distress syndrome.Randomized Clinical Trial of a Combination of an Inhaled Corticosteroid and Beta Agonist in Patients at Risk of Developing the Acute Respiratory Distress Syndrome.ARDS following oesophagectomy: a comparison of two trials.Frontline Science: D1 dopaminergic receptor signaling activates the AMPK-bioenergetic pathway in macrophages and alveolar epithelial cells and reduces endotoxin-induced ALI.Pharmacotherapy for Adult Patients with Acute Respiratory Distress Syndrome.

P2860

Q26822605-C274AC03-ACC0-4F05-A5B4-55E80AE411A0 Q27009192-429F5C10-3B64-4FB2-ACEF-F8F2C81B264D Q33901620-B3EFA36B-0FB1-4587-B07C-14A8A9E435D2 Q34299807-88405374-0876-4477-8C09-A56AE3B61391 Q35830022-C362B126-06FB-4A50-89C1-A98A47F226AB Q37670540-E3066FB3-0195-4DDF-BB74-D5373A7E3C18 Q38261259-BF6FF8FC-461C-4570-8337-336625909F91 Q38527919-CB7F3C4C-45C2-4B84-BF67-BFD681EEF58D Q38642506-D12F7E6E-5EF5-44FF-919A-342342C46DE6 Q38775825-0FE5568D-EE41-446A-BF2A-9363A3D86070 Q41190745-D757E3DD-27A3-46A2-BAD7-4375303347E9 Q42358572-FAE561D0-2FFF-41A9-9173-5E5A4B14544F Q42735832-0595751F-14F2-4FEC-9EE0-B06B4BBB7679 Q42735835-F46AFBAF-16D7-4316-BB36-B3FC5E4889E6 Q44663643-1991BA33-B54A-4BB2-914B-F91D12420C76 Q50052440-94915DCB-63EF-49A9-87DB-F9585A458B84 Q51401647-E1926A06-DF04-479F-827B-D9E42964AA99 Q55235361-06CEA0F9-1DEE-42D7-8714-D52ED066DF2B

P2860

The beta agonist lung injury trial prevention. A randomized controlled trial.

http://www.wikidata.org/entity/Q37698243

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on March 2014

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

The beta agonist lung injury trial prevention. A randomized controlled trial.

@en

The beta agonist lung injury trial prevention. A randomized controlled trial.

@nl

type

label

The beta agonist lung injury trial prevention. A randomized controlled trial.

@en

The beta agonist lung injury trial prevention. A randomized controlled trial.

@nl

prefLabel

The beta agonist lung injury trial prevention. A randomized controlled trial.

@en

The beta agonist lung injury trial prevention. A randomized controlled trial.

@nl

P1433

Q37698243-678DC924-6493-4749-BA2F-D30B6DE298A6

P1476

Q37698243-FAE2F91C-6732-47AE-9E61-4445234AAD9A

P2093

Q37698243-09FE48AF-4CD5-4F8D-AB97-43480EBAF991

Q37698243-421E8378-D8F5-4048-9335-C0587ADBE3EF

Q37698243-774A0776-E275-49D5-B063-9D5667565259

Q37698243-7841447D-37AC-4011-B8E8-FD8C3241FAF6

Q37698243-79755EE6-6858-4862-A496-9E8530AD4CF9

Q37698243-86E41917-4CD9-4BEA-9130-7D1DC7D239A6

Q37698243-9DA0DD2A-6D91-4215-8040-E34E0A19157E

Q37698243-A21C56E7-0A53-4B4B-90AF-9557AEBDB489

Q37698243-D60B9460-8126-4D12-8A00-6A727CC3CB92

Q37698243-ED7CECE4-D95C-46E5-9484-7408B568A695

P2860

Q37698243-037C80C3-57EB-4BFB-A36D-784520763BF0

Q37698243-0A9D2C20-2013-44AE-AB76-A186A63A7A96

Q37698243-0DFE900A-A688-462D-9526-5E3A2217D2F6

Q37698243-14CD7145-7853-41D5-AF89-CF4BE63DB25B

Q37698243-1F548C5B-C191-4BE1-AA59-98B71F782139

Q37698243-2367B8AD-A649-456B-ABB0-4EA9027F96BD

Q37698243-23EA4D8F-B6AE-44CB-9337-B52AD23F1910

Q37698243-2C55234B-FF6A-475E-BE0D-DFAD7DB8A4BE

Q37698243-33D2C83C-4EA0-4FAE-85AD-4750E924DA7E

Q37698243-3670B235-B9B8-4C1D-B2B7-15623E18CC8B

P304

Q37698243-901C4567-4A0D-4E8A-8B89-B0F80D39624E

P31

Q37698243-31D2C269-8E00-4239-B748-814E5E101841

P356

Q37698243-B69EC757-F9FE-417C-946F-EC90E0BE0CB7

P407

Q37698243-C8D583B5-FF4D-44F6-91B0-A4C76285D210

P433

Q37698243-FCB80414-6834-4D10-8276-5EC5E6FC7DF4

P478

Q37698243-FC518A8A-3BF8-4127-9B91-C56EADB7B66F

P50

Q37698243-25EB956F-906C-460F-A688-93A33548FC05

Q37698243-B0A6CF9C-EBAC-45E4-97C1-D646CD9A27FF

Q37698243-E3E9B862-C6FA-4E2A-8B22-C963E2DD638A

P577

Q37698243-8D7A2D53-8EE8-4E5E-8F3D-7981A72E2B60

P698

Q37698243-E29E42DD-3E20-41A0-A5F0-E9F6103768D7

P932

Q37698243-1CF40B89-02CE-41D3-9738-8A1822C0FC3C

P356

RCCM.201308-1549OC

P1433

American Journal of Respiratory and Critical Care Medicine

P1476

The beta agonist lung injury trial prevention. A randomized controlled trial

@en

P2093

BALTI-Prevention Collaborators

http://www.w3.org/2001/XMLSchema#string

Ben Holloway

http://www.w3.org/2001/XMLSchema#string

Chris Knox

http://www.w3.org/2001/XMLSchema#string

Daniel Park

http://www.w3.org/2001/XMLSchema#string

Fang Gao

http://www.w3.org/2001/XMLSchema#string

James Ryan

http://www.w3.org/2001/XMLSchema#string

Joseph Marzouk

http://www.w3.org/2001/XMLSchema#string

Matthew W Cooke

http://www.w3.org/2001/XMLSchema#string

Sarah E Lamb

http://www.w3.org/2001/XMLSchema#string

Simon Gates

http://www.w3.org/2001/XMLSchema#string

P2860

Global cancer statistics

Bench-to-bedside review: beta2-Agonists and the acute respiratory distress syndrome

Randomized, placebo-controlled clinical trial of an aerosolized β₂-agonist for treatment of acute lung injury.

Derivation and diagnostic accuracy of the surgical lung injury prediction model.

Biomarkers of lung epithelial injury and inflammation distinguish severe sepsis patients with acute respiratory distress syndrome.

Relationship between extravascular lung water and severity categories of acute respiratory distress syndrome by the Berlin definition

Use of the SOFA score to assess the incidence of organ dysfunction/failure in intensive care units: results of a multicenter, prospective study. Working group on "sepsis-related problems" of the European Society of Intensive Care Medicine.

The Beta Agonist Lung Injury TrIal (BALTI)--prevention trial protocol.

Effect of intravenous β-2 agonist treatment on clinical outcomes in acute respiratory distress syndrome (BALTI-2): a multicentre, randomised controlled trial.

The clinical usefulness of extravascular lung water and pulmonary vascular permeability index to diagnose and characterize pulmonary edema: a prospective multicenter study on the quantitative differential diagnostic definition for acute lung injury/

P304

674-683

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1164/RCCM.201308-1549OC

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

189

http://www.w3.org/2001/XMLSchema#string

P50

David R Thickett

Daniel F McAuley

Gavin D Perkins

P577

2014-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24392848

http://www.w3.org/2001/XMLSchema#string

P932

3983838

http://www.w3.org/2001/XMLSchema#string